Key result
Hospitalization primarily for tricuspid regurgitation in patients with HFpEF was associated with a higher risk of all-cause death compared to non-TR causes.
Why the study?
The clinical impact of tricuspid regurgitation on the long-term prognosis of heart failure with preserved ejection fraction remains unclear.
Does hospitalization for tricuspid regurgitation increase mortality in patients with HFpEF?
Cohort (n=4,456)
Yes
Does hospitalization for tricuspid regurgitation increase mortality in patients with HFpEF?
Answers are grounded in this paper and cite their sources.
Hospitalization for tricuspid regurgitation in patients with HFpEF is associated with a poor prognosis, with mortality rates comparable to those hospitalized for aortic stenosis.
Background: The clinical impact of tricuspid regurgitation (TR) on the long-term prognosis of heart failure with preserved ejection fraction (HFpEF) remains unclear. Methods and Results: We analyzed the data of 4,456 patients with HFpEF from the Japanese Registry of Acute Decompensated Heart Failure (JROADHF) and identified 83 patients hospitalized primarily for TR. They had a higher mortality rate than those without TR. The 1- and 4-year mortality rates in the TR group were comparable with those for patients hospitalized primarily for aortic stenosis. Conclusions: Hospitalization for TR is associated with a poor prognosis in patients with HFpEF.
No takes yet. Share an insight, caveat, or question.
Tohyama et al. (2026) conducted a cohort in Heart Failure with Preserved Ejection Fraction (HFpEF) (n=4,456). Hospitalization primarily for tricuspid regurgitation vs. Hospitalization for non-TR causes was evaluated on All-cause death (HR 1.40, 95% CI 1.14-1.71, p=<0.001). Hospitalization primarily for tricuspid regurgitation in patients with HFpEF was associated with a higher risk of all-cause death compared to non-TR causes.
Synapse has enriched 10 related papers. Consider them for comparative context: